Disclosures. Amit Nathwani MD — Nothing to disclose. Frank Leebeek MD — Consultant: CSL Behring, Takeda, Biomarin. Researcher: Takeda, CSL Behring, SOBI. Robert Klamroth MD — Consultant: Bayer, BioMarin, Chugai , CSL Behring, Roche, Novo Nordisk, Octapharma, Pfizer, Sanofi, SOBI, Takeda. Researcher: BioMarin, CSL Behring, Roche, Novo Nordisk, Octapharma, Pfizer, Sanofi, SOBI. Speaker: Bayer, BioMarin, Biotest, Chugai , CSL Behring, Roche, Grifols, Kedrion, LEO Pharma, LFB, Novo Nordisk, Octapharma, Pfizer, Sanofi, SOBI, Takeda, Viatris. Wolfgang Miesbach MD (moderator) — Consultant: Bayer, Biomarin, Biotest, CSL Behring, Chugai, Freeline, LFB, Novo Nordisk, Octapharma, Pfizer, Regeneron, Roche, Sanofi, Takeda/Shire, uniQure. Dorothy Caputo, MA, BSN, RN - President — Nothing to disclose. Michele Bielarski, RN (planner/reviewer) — Nothing to disclose. AKH Inc Staff and Planners — Nothing to disclose. Orakle LLC Staff and Planners — Nothing to disclose. All of the relevant financial relationships listed for these individuals have been mitigated.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product. This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer. This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with “Opt Out” in the subject line.